WebDisclosure WebDisclosure
Basculer en Français
10990 Companies
240749 Keywords
169424 Articles
129585 Press releases
Headlines Articles Press releases First Breach Remove
  1. Home
  2. Companies
  3. First Breach
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 08/20/2026 at 17:25, 26 days ago

    First Breach commence à être négocié sur le NASDAQ

    Partenariats Stratégiques Industrie De Défense Cotation Au Nasdaq Technologies De Drones Première Brèche
  • PRESS RELEASE

    published on 08/20/2026 at 17:20, 26 days ago

    First Breach Begins Trading on NASDAQ Under Ticker Symbol "FBDT"

    First Breach Inc., an American defense technologies company, lists common stock on Nasdaq. Expanding ammunition production and drone technologies
    Nasdaq Listing Defense Manufacturing Drone Technologies First Breach Inc. Ammunition Production
    Logo of First Breach
Previous page
1 2
Accesswire
  • Published on 09/15/2026 at 17:00, 36 minutes ago

    PPX Intercepts High-Grade Gold, Silver, and Copper at Callanquitas, Including 20.04 g/t Au over 0.85 m and 2251 g/t Ag With 3.0% Cu over 0.90 m

  • Published on 09/15/2026 at 16:35, 1 hour 1 minute ago

    Innodata Appoints Admiral Michael S. Rogers, Former NSA Director and Commander of U.S. Cyber Command, to Its Board of Directors

  • Published on 09/15/2026 at 15:45, 1 hour 51 minutes ago

    Galaxy Ventures Inc. Announces Major Milestones for Qualifying Transaction: TruSilver Completes $2.5 Million Financing and Appoints Former IAMGOLD Chief Geologist Matt Rees as Director and Vice-President of Exploration

  • Published on 09/15/2026 at 15:35, 2 hours 1 minute ago

    Revive Therapeutics to Expand Bucillamine IP and Orphan Drug Portfolio Across Medical Countermeasures and Rare Diseases

  • Published on 09/15/2026 at 15:25, 2 hours 11 minutes ago

    Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in 
DR Congo with 48% Crude Fatality Rate, Says NanoViricides

View all ACCESSWIRE
EQS Group
  • Published on 09/15/2026 at 16:43, 52 minutes ago

    DEAG: Bondholders approve amendment of the bond terms and conditions ("Notice of Results of a Written Resolution")

  • Published on 09/15/2026 at 16:10, 1 hour 26 minutes ago

    Duck Creek Closes Fiscal Year 2026 with Record Bookings as Insurers Accelerate Core Systems Modernization and Agentic AI Adoption

  • Published on 09/15/2026 at 16:05, 1 hour 31 minutes ago

    NOVVA Group secures landmark 3.17 GW renewable energy portfolio from ABO Energy to power global AI infrastructure

  • Published on 09/15/2026 at 16:01, 1 hour 34 minutes ago

    Director/PDMR Shareholding

  • Published on 09/15/2026 at 15:22, 2 hours 13 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

View all EQS
Les Echos
  • Published on 09/15/2026 at 17:01, 34 minutes ago

    Number of shares and voting rights - August 2026 (In French only)

  • Published on 09/15/2026 at 17:01, 34 minutes ago

    Nombre total d'actions et droits de vote - août 2026

  • Published on 09/15/2026 at 07:00, 10 hours 36 minutes ago

    AXA announces its 2027-2029 strategy and financial targets

  • Published on 09/15/2026 at 07:00, 10 hours 36 minutes ago

    AXA annonce son plan stratégique 2027-2029 ainsi que ses objectifs financiers

  • Published on 09/14/2026 at 18:21, 23 hours 15 minutes ago

    Reporting on share buyback transactions carried out between September 7 and September 10, 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy